Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1983 Oct;198(4):541-5.
doi: 10.1097/00000658-198310000-00014.

Nuclear magnetic resonance for the differentiation of benign and malignant breast tissues and axillary lymph nodes

Comparative Study

Nuclear magnetic resonance for the differentiation of benign and malignant breast tissues and axillary lymph nodes

E T Fossel et al. Ann Surg. 1983 Oct.

Abstract

We have utilized proton T1 (spin-lattice relaxation time) values of Nuclear Magnetic Resonance to study 110 tissue samples obtained from 11 mastectomy specimens. Samples of 1 cm3 from primary tumor sites, nipples, and other breast quadrants, as well as intact lymph nodes were studied and then histologically scored for the presence or absence of carcinoma and, if present, whether it was an isolated microscopic focus (micro). Of 54 samples of breast tissue, 12 contained carcinoma, 5 micro: of 45 lymph nodes, 15 contained metastatic carcinoma, 2 micro; of the 11 nipples, 2 had carcinoma, both micro. For the malignant samples (excluding micro) mean T1 value was 0.47 +/- 0.07 sec, (range 0.39-0.79 sec). For the 72 benign samples (excluding nipple) mean T1 value was 0.26 +/- 0.03 sec (range 0.14-0.36 sec). The 13 tumor-bearing nodes had a mean T1 value of 0.47 +/- 0.03 sec (range 0.40-0.63 sec); mean for the benign nodes was 0.26 +/- 0.007 sec (range 0.19-0.35 sec). The differences were highly significant in each case (p less than 0.001). For micro examples, T1 values were at malignancy threshold levels or just below, except for nipple tissues, where discrimination was poor. For the 20 other malignant samples, there was no correlation between T1 value and the per cent of sample containing malignancy.

PubMed Disclaimer

References

    1. Br J Cancer. 1978 Oct;38(4):547-54 - PubMed
    1. J Natl Cancer Inst. 1974 Jun;52(6):1849-53 - PubMed
    1. N Engl J Med. 1981 May 28;304(22):1360-1 - PubMed
    1. Br J Radiol. 1977 Mar;50(591):188-94 - PubMed
    1. Science. 1971 Mar 19;171(3976):1151-3 - PubMed

Publication types